K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

0
Player Avatar MajorBob04 (88.33) Submitted: 2/7/2012 7:16:04 AM : Outperform Start Price: $3.01 KV-A Score: -47.80

Here we go again. . .

Report this Post 1 Comment
Member Avatar PKCIvestments (< 20) Submitted: 2/10/2012 7:22:04 PM
Recs: 0

Where are we going?

Featured Broker Partners


Advertisement